Mr. Darcy Bomford reports

CANNABIS EXPERTS JOIN TRUE LEAF TEAM FOR FINAL MARIJUANA LICENSING REVIEW STAGE

True Leaf Medicine Inc., a division of True Leaf Medicine International Ltd., has engaged a number of cannabis experts to guide the company through the final stage in Health Canada's review of its application for a licence to produce marijuana in Canada.

Experts from industry-leading Pipe Dreemz Inc., Protect-IP Global Solutions Inc., Eurofins Scientific and Ample Organics will be working with True Leaf over the next few weeks to prepare a review package for submission to Health Canada under the access to cannabis for medical purposes regulations (ACMPR) application process.

Health Canada recently upgraded the marijuana for medical purposes regulations (MMPR) application process to the ACMPR licensing program, so the experts will be working with True Leaf to update its original MMPR application to ensure True Leaf meets or exceeds the new compliance measures.

"True Leaf is excited to have Pipe Dreemz, Protect-IP, Eurofins and Ample Organics provide their expertise at this critical stage in the ACMPR review process," said True Leaf chief executive officer Darcy Bomford. "We sought out experts from these companies because several of their clients have already been successful in the ACMPR process."

True Leaf has engaged Pipe Dreemz chief executive officer George Routhier, a premier consultant to companies going through Health Canada's marijuana for medical purposes regulations (MMPR) or ACMPR process since 2012. Mr. Routhier helps his clients navigate the complexities of the licensing process, specifically the design, construction and operating procedures of marijuana production facilities. Pipe Dreemz is currently advising clients with over $150-million in production facilities under construction in Canada.

Protect-IP will advise True Leaf on the physical safety integration of its planned production facility. Protect-IP's engineering team has worked with companies in all phases of the licensing process, and will work with True Leaf on developing procedures for control systems, alarm systems and CCTV (closed-circuit television) using IP (Internet protocol) technology to ensure True Leaf builds and operates a safe and secure production facility.

Eurofins, a leading international group of laboratories with more than 22,000 employees across 225 sites in 39 countries, will help True Leaf test its marijuana products to ensure it complies with Health Canada regulations. Eurofins works with the pharmaceutical, food, environmental and consumer products industries on a wide range of scientific testing and support services.

True Leaf has also engaged Ample Organics, the most widely adopted seed-to-sale reporting system among Canada's licensed marijuana producers.

"We are pleased to be working with True Leaf, a late-stage ACMPR applicant," said Mr. Routhier. "Darcy and his team have chosen to accelerate their final push to the finish line, and together we expect to receive their prelicence inspection in the very near future."

About True Leaf Medicine International Ltd.

True Leaf Medicine International, through its wholly owned subsidiary True Leaf Pet, has entered the $104.9-billion global pet care industry with a line of hemp-focused pet chews and supplements marketed through natural pet health and veterinary channels in Canada, the United States and Europe. The company has also filed an application under Health Canada's access to cannabis for medical purposes regulations (ACMPR) to become a Canadian licensed producer through its True Leaf Medicine subsidiary. It has passed through the preliminary and enhanced screening process of Health Canada's review and is currently awaiting security clearance and prelicensing inspection approval.